China News Service, October 26. According to the website of the State Drug Administration, the World Health Organization recently stated that the domestic bivalent human papillomavirus vaccine (Xinkening®, Cecolin®) produced by Xiamen Wantai Canghai Biotechnology Co., Ltd. ) Has officially passed its pre-certification and is available for procurement by the United Nations system.

  Xinkening Bivalent Human Papillomavirus Vaccine (Type 16 and Type 18) is a vaccine for injection. It is valid for 24 months under storage conditions of 2-8°C.

  The Xinkening bivalent human papillomavirus vaccine has been pre-certified by the World Health Organization, becoming the sixth pre-certified domestic vaccine in China, marking that China's vaccine product supervision, development and production system and product quality have achieved international standards. widely accepted.

Vaccination against human papillomavirus will benefit women from all over the world, especially in developing countries, and promote the realization of the World Health Organization’s "Global Strategy for Accelerating the Elimination of Cervical Cancer."